Compile Data Set for Download or QSAR
maximum 50k data
Found 53 Enz. Inhib. hit(s) with all data for entry = 3117
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391797(6-((7-(3-Chloro-4-cyanophenyl)-5,6,7,8-tetrahydrop...)
Affinity DataIC50:  2nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391776(6-((7-(4-Cyano-3-(trifluoromethyl)phenyl)-5,6,7,8-...)
Affinity DataIC50:  20nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391759(6-((7-(4-Cyano-3-(trifluoromethyl)phenyl)-5,6,7,8,...)
Affinity DataIC50:  30nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391789(4-(4-((5-(4-(2-Hydroxypropan-2-yl)piperidin-1-carb...)
Affinity DataIC50:  34nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391792(2-Bromo-4-(4-((5-(2-hydroxypropan-2-yl)pyridin-2-y...)
Affinity DataIC50:  50nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391802(2-Chloro-4-(4-((5-(2-methyl-2-(1H-tetrazol-1-yl)pr...)
Affinity DataIC50:  55nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391774(2-((7-(4-Cyano-3-(trifluoromethyl)phenyl)-5,6,7,8-...)
Affinity DataIC50:  60nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391779(6-((7-(4-Cyano-3-(trifluoromethyl)phenyl)-5,6,7,8-...)
Affinity DataIC50:  60nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391795(4-(4-((4-Fluoro-5-(2-hydroxypropan-2-yl)pyridin-2-...)
Affinity DataIC50:  70nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391772(6-((7-(4-Cyano-3-(trifluoromethyl)phenyl)-5,6,7,8-...)
Affinity DataIC50:  70nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391752(2-Chloro-4-(4-((6-(2-hydroxypropan-2-yl)pyridazin-...)
Affinity DataIC50:  70nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391730(4-(4-((1,2,4-Thiadiazol-5-yl)amino)-5,6-dihydropyr...)
Affinity DataIC50:  80nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391758(4-(4-((6-(2-Hydroxypropan-2-yl)pyridazin-3-yl)amin...)
Affinity DataIC50:  90nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391775(6-((7-(4-Cyano-3-(trifluoromethyl)phenyl)-5,6,7,8-...)
Affinity DataIC50:  90nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391768(4-(4-((5-((1,4-Oxazepan-4-yl)sulfonyl)thiazol-2-yl...)
Affinity DataIC50:  100nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391761(4-(4-((6-Isopropoxypyridin-3-yl)amino)-5,6-dihydro...)
Affinity DataIC50:  110nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391763(4-(4-((6-(2-(1H-1,2,3-Triazol-1-yl)ethoxy)pyridin-...)
Affinity DataIC50:  130nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391767(6-((7-(4-Cyano-3-(trifluoromethyl)phenyl)-5,6,7,8-...)
Affinity DataIC50:  130nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391800(4-(4-((5-Chloro-6-(2-methyl-2-(1H-tetrazol-1-yl)pr...)
Affinity DataIC50:  150nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391753(4-(4-((5-(2-Hydroxypropan-2-yl)pyridin-2-yl)amino)...)
Affinity DataIC50:  160nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391784((R)—N-(1-(1,3,4-Oxadiazol-2-yl)ethyl)-2-((7-(...)
Affinity DataIC50:  170nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391783(6-((7-(4-Cano-3-(trifluoromethyl)phenyl)-5,6,7,8-t...)
Affinity DataIC50:  170nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391765(4-(4-((5-(2-Methyl-2-(1H-tetrazol-1-yl)propoxy)pyr...)
Affinity DataIC50:  170nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391760(4-(4-((5-(1-Hydroxycyclopropyl)pyridin-2-yl)amino)...)
Affinity DataIC50:  170nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391782(5-((7-(4-Cano-3-(trifluoromethyl)phenyl)-5,6,7,8-t...)
Affinity DataIC50:  190nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391751(4-(4-((6-Fluoro-5-(2-hydroxypropan-2-yl)pyridin-2-...)
Affinity DataIC50:  190nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391777(6-((7-(3-Chloro-4-cyanophenyl)-5,6,7,8-tetrahydrop...)
Affinity DataIC50:  200nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391764(4-(4-((6-(2-Methyl-2-(1H-tetrazol-1-yl)propoxy)pyr...)
Affinity DataIC50:  210nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391755(2-Chloro-4-(4-((5-(2-hydroxypropan-2-yl)pyridin-2-...)
Affinity DataIC50:  250nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391754(4-(4-((5-(2-Hydroxypropan-2-yl)-4-(trifluoromethyl...)
Affinity DataIC50:  250nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391794(2-Chloro-4-(4-((6-fluoro-5-(2-hydroxypropan-2-yl)p...)
Affinity DataIC50:  250nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391787((R)-6-((7-(4-Cyano-3-(trifluoromethyl)phenyl)-5,6,...)
Affinity DataIC50:  260nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391762(4-(4-((4-(2-(1-Methyl-1H-pyrazol-5-yl)ethoxy)pheny...)
Affinity DataIC50:  300nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391780(5-((7-(4-Cyano-3-(trifluoromethyl)phenyl)-5,6,7,8-...)
Affinity DataIC50:  310nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391798(4-(4-((5-Fluoro-6-(2-methyl-2-(1H-tetrazol-1-yl)pr...)
Affinity DataIC50:  320nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391766(4-(4-((4-(3-(4-(Methylsulfonyl)piperazin-1-yl)prop...)
Affinity DataIC50:  360nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391770(2-(6-((7-(4-Cyano-3-(trifluoromethyl)phenyl)-5,6,7...)
Affinity DataIC50:  370nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391748(4-(4-((4-Isopropoxyphenyl)amino)-5,6-dihydropyrido...)
Affinity DataIC50:  370nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391769(2,2,2-Trifluoroethyl (6-((7-(4-cyano-3-(trifluorom...)
Affinity DataIC50:  380nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391778(2-((7-(4-Cyano-3-(trifluoromethyl)phenyl)-5,6,7,8-...)
Affinity DataIC50:  390nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391796(5-((7-(4-Cyano-3-(trifluoromethyl)phenyl)-5,6,7,8-...)
Affinity DataIC50:  490nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391749(4-(4-((4-Methoxyphenyl)amino)-5,6-dihydropyrido[3,...)
Affinity DataIC50:  530nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391785((R)—N-(1-(1,3,4-Oxadiazol-2-yl)ethyl)-6-((7-(...)
Affinity DataIC50:  560nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391750(4-(4-((1,1′-Biphenyl)-3-ylamino)-5,6-dihydro...)
Affinity DataIC50:  620nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391781(2-((7-(4-Cyano-3-(trifluoromethyl)phenyl)-5,6,7,8-...)
Affinity DataIC50:  700nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391791(4-(4-((5-(4-(2-Hydroxypropan-2-yl)piperidin-1-carb...)
Affinity DataIC50:  790nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391771(N-(6-((7-(4-Cano-3-(trifluoromethyl)phenyl)-5,6,7,...)
Affinity DataIC50:  800nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391803(2-Chloro-4-(4-((6-fluoro-5-(1-hydroxycyclobutyl)py...)
Affinity DataIC50:  840nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391793(2-Chloro-4-(4-((4-fluoro-5-(2-hydroxypropan-2-yl)p...)
Affinity DataIC50:  940nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetAndrogen receptor(Homo sapiens (Human))
Taiho Pharmaceutical

US Patent
LigandPNGBDBM391799(4-(4-((5-Fluoro-6-(2-methyl-2-(1H-1,2,3-triazol-1-...)
Affinity DataIC50:  1.10E+3nMAssay Description:Antagonist activity for AR was evaluated according to the following method. COS-7 cells (ATCC) were transfected with pMMTV-luc vector (reporter plasm...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 53 total ) | Next | Last >>
Jump to: